Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

A strain of Bifidobacterium bifidum and its application in relieving intestinal injury

A technology of Bifidobacterium bifidum and viable count, applied in the field of microorganisms to reduce mortality, alleviate or prevent acute colon tissue damage, and improve weight loss

Active Publication Date: 2022-07-05
JIANGNAN UNIV
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, so far, there is no patent report that Bifidobacterium bifidum can relieve acute intestinal injury

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A strain of Bifidobacterium bifidum and its application in relieving intestinal injury
  • A strain of Bifidobacterium bifidum and its application in relieving intestinal injury
  • A strain of Bifidobacterium bifidum and its application in relieving intestinal injury

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Example 1: Isolation and screening of Bifidobacterium bifidum CCFM1172

[0035] 1. Sample Collection

[0036] The stool samples of healthy infants in Jiangning District, Nanjing City, Jiangsu Province were collected. The samples were placed in a preservation tube containing 30% glycerol, and stored in an incubator with an ice pack. After being brought back to the laboratory, they were quickly placed in a -80°C refrigerator for separation. filter.

[0037] 2. Isolation and purification of bifidobacteria

[0038] (1) Dilution coating: In a sterile environment, take about 0.5 g of a mixture of 30% glycerol and feces and add it to a 10 mL centrifuge tube of 4.5 mL of normal saline to obtain 10 -1 Diluent, repeat the above dilution steps to obtain 10 in turn -2 , 10 -3 , 10 -4 , 10 -5 , 10 -6 Diluent;

[0039] (2) Coating culture: Pipette 100 μL of the above 10 -4 , 10 -5 , 10 -6Three gradient sample dilutions were prepared in MRS fixed medium containing 0.1% cyst...

Embodiment 2

[0050] Example 2: Gavage of CCFM1172 before and after TNBS-induced colon injury has a significant protective effect

[0051] 1. Preparation of bacterial suspension

[0052] The Bifidobacterium bifidum CCFM1172 in the glycerol storage tube obtained in Example 1 was spread on the MRS solid plate, and cultivated in an anaerobic workstation at 37°C for 48 hours; a single colony was picked and inoculated in 5 mL MRS medium, and then placed in an anaerobic workstation. Incubate at 37 °C for 36 h; expand the activated bacterial solution to 1 L of MRS medium, cultivate in an anaerobic workstation at 37 °C for 2 days, centrifuge at 8000 r / min for 20 min, collect the bacterial slurry, and resuspend with PBS to adjust the viability. Bacteria count to 5×10 9 CFU / mL, aliquot into small portions, store in a 4°C refrigerator for later use, and use up within 5 days. Referring to the same method, Bifidobacterium bifidum CCFM16 and Bifidobacterium bifidum FHNXY17M1 bacterial suspensions scree...

Embodiment 3

[0068] Example 3: Therapeutic effect of CCFM1172 after TNBS-induced colon injury

[0069] 1. Experimental method

[0070] The preparation of the bacterial suspension and the experimental animals were the same as in Example 2.

[0071] Drug preparation method: 5% TNBS aqueous solution was prepared into 20ug / uL 35% ethanol aqueous solution with 75% ethanol solution and sterile water (ethanol concentration 35%, TNBS concentration 20ug / uL).

[0072] Eight-week-old male Balb / c mice were randomly divided into 3 groups, including a modeling group, a treatment group with Bifidobacterium bifidum CCFM1172, and a blank group, with 10 mice in each group. Mice were acclimated to the SPF barrier environment for one week and fasted for 24 hours. Then, the mice in the modeling group and the treatment group were rectally perfused with 50 uL of ethanolic TNBS solution using a syringe connected to a plastic hose, and the blank group was perfused with 35% ethanol solution in the same way. Ethan...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a strain of Bifidobacterium bifidum and its application in relieving intestinal damage, belonging to the field of microorganisms. Bifidobacterium bifidum CCFM1172 of the present invention can significantly alleviate or prevent acute colon tissue damage, improve weight loss, mouse laziness, chills, reduced eating, dull and uneven coat color, diarrhea and other disease states, and the mortality rate is reduced from 53% to 0%. Therefore, the Bifidobacterium bifidum of the present invention can be used to prepare food, medicine or health care product for relieving or preventing acute colon injury, and has wide application prospects.

Description

technical field [0001] The invention relates to a strain of Bifidobacterium bifidum and its application in relieving intestinal damage, and belongs to the field of microorganisms. Background technique [0002] Bifidobacterium bifidum, a probiotic bacteria, has received some attention due to its potential benefits to human health. Bifidobacterium bifidum was the first colonizer in the neonatal gastrointestinal tract due to its ability to metabolize human milk oligosaccharides. A study by Elahe et al. demonstrated that specific Bifidobacterium bifidum efficiently induced antitumor immune responses and inhibited the growth of human papillomavirus (HPV)-associated TC-1 tumor cells in C57BL / 6 mice. Clinical trial results by Viola et al. suggest that specific Bifidobacterium bifidum can alleviate symptoms of irritable bowel syndrome (IBS). A study by Ahamd et al. showed that specific Bifidobacterium bifidum bacteria can alleviate DSS-induced colitis and partially restore the mal...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N1/20A61K35/745A61P1/00A23L33/135A23L2/38A23L2/84A23C9/123A23L11/65A23L11/50C12R1/01
CPCC12N1/20A61K35/745A61P1/00A23L33/135A23L2/382A23L2/84A23C9/1234A23C11/106A23V2002/00A23V2400/123A23V2400/249A23V2400/517A23V2200/3204Y02A50/30
Inventor 翟齐啸李晶冯赛赛陈卫于雷雷田丰伟陆文伟崔树茂王刚赵建新张灏
Owner JIANGNAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com